NCT03369925

Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

A Parallel, Double-Blind Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) in Men and Women With Age-Associated Memory Impairment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Kyowa Hakko Bio Co., Ltd. · Industry
• Sex: All
• Age: 50 Years – 85 Years
• Healthy volunteers: Accepted

Summary

The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.

Detailed description

This study is a 12-week, randomized, double-blind, placebo-controlled trial of citicoline in healthy men and women with Age-Associated Memory Impairment. Cognitive assessments will be performed to determine whether citicoline administration with supportive memory, compared to placebo administration.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo supplement	Cellulose
DIETARY_SUPPLEMENT	Citicoline supplement	Cognizin

Timeline

• Start date: 2018-01-02
• Primary completion: 2018-12-03
• Completion: 2018-12-03
• First posted: 2017-12-12
• Last updated: 2019-02-27

Locations

1 site across 1 country: United States